Corvus Pharmaceuticals
CRVS
CRVS
56 hedge funds and large institutions have $44.9M invested in Corvus Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
-5
Holders Change %
-8.2%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
14
Reduced
17
Closed
12
Calls
$174K
Puts
$337K
Net Calls
-$163K
Net Calls Change
-$179K
Top Buyers
Top Sellers
| 1 |
AFM
1
Anson Funds Management
Dallas,
Texas
|
$0 |
| 2 |
2
Two Sigma Investments
New York
|
$827K |
| 3 |
VA
3
VR Adviser
New York
|
$0 |
| 4 |
4
Two Sigma Advisers
New York
|
$684K |
| 5 |
5
Millennium Management
New York
|
$4.47M |
